Cancer Research Cancer Epigenetics EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paz, M. F.
Right arrow Articles by Esteller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paz, M. F.
Right arrow Articles by Esteller, M.
[Cancer Research 63, 1114-1121, March 1, 2003]
© 2003 American Association for Cancer Research

Tumor Biology

A Systematic Profile of DNA Methylation in Human Cancer Cell Lines1

Maria F. Paz, Mario F. Fraga, Sonia Avila, Mingzhou Guo, Marina Pollan, James G. Herman and Manel Esteller2

Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Center [M. F. P., M. F. F., S. A., M. E.] and Cancer Epidemiology Unit, Spanish National Center for Epidemiology, Carlos III Institute of Health [M. P.], 28029 Madrid, Spain, and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231 [M. G., J. G. H.]

Human cancer cell lines are commonly used in basic cancer research to understand the behavior of primary tumors. Aberrations in the DNA methylation patterns are nowadays recognized as a hallmark of the cancer cell. However, no comprehensive study defines the DNA methylation environment present in the established cancer cell lines used in everyday laboratory-based research. To address this matter, we have analyzed 70 widely used human cancer cell lines of 12 different tumor types for CpG island promoter hypermethylation of 15 tumor suppressor genes, global 5-methylcytosine genomic content, chemical response to the demethylating agent 5-aza-2'-deoxycytidine, and their genetic haplotype for methyl-group metabolism genes. Several conclusions arise from our study: (a) a specific profile of CpG island hypermethylation exists for each tumor type, allowing its classification within hierarchical clusters according to the originating tissue; (b) cancer cell lines generally have higher levels of CpG island hypermethylation than primary tumors, because of the contribution of particular CpG islands and tumor types; and (c) there are no major differences between cell lines in their 5-methylcytosine DNA content, efficacy of 5-aza-2'-deoxycytidine treatment, and distribution of allelotypes of methyl-group metabolism genes. Our data provide a basis for a better use of human cancer cell lines in basic and translational research with respect to their DNA methylation environment.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
B. J. Evison, R. A. Bilardi, F. C. K. Chiu, G. Pezzoni, D. R. Phillips, and S. M. Cutts
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity
Nucleic Acids Res., October 1, 2009; 37(19): 6355 - 6370.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
A. L. Brunner, D. S. Johnson, S. W. Kim, A. Valouev, T. E. Reddy, N. F. Neff, E. Anton, C. Medina, L. Nguyen, E. Chiao, et al.
Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver
Genome Res., June 1, 2009; 19(6): 1044 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. Xiong and R. J. Epstein
Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status
Mol. Cancer Ther., April 1, 2009; 8(4): 779 - 785.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. I. Martin-Subero, M. Kreuz, M. Bibikova, S. Bentink, O. Ammerpohl, E. Wickham-Garcia, M. Rosolowski, J. Richter, L. Lopez-Serra, E. Ballestar, et al.
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling
Blood, March 12, 2009; 113(11): 2488 - 2497.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Rius, C. Stresemann, D. Keller, M. Brom, E. Schirrmacher, D. Keppler, and F. Lyko
Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation
Mol. Cancer Ther., January 1, 2009; 8(1): 225 - 231.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Aleman, V. Cebrian, M. Alvarez, V. Lopez, E. Orenes, L. Lopez-Serra, F. Algaba, J. Bellmunt, A. Lopez-Beltran, P. Gonzalez-Peramato, et al.
Identification of PMF1 Methylation in Association with Bladder Cancer Progression
Clin. Cancer Res., December 15, 2008; 14(24): 8236 - 8243.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
K. Amara, M. Trimeche, S. Ziadi, A. Laatiri, M. Hachana, and S. Korbi
Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas
Ann. Onc., October 1, 2008; 19(10): 1774 - 1786.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Q. Li, L. Tang, P. C. Roberts, J. M. Kraniak, A. L. Fridman, O. I. Kulaeva, O. S. Tehrani, and M. A. Tainsky
Interferon Regulatory Factors IRF5 and IRF7 Inhibit Growth and Induce Senescence in Immortal Li-Fraumeni Fibroblasts
Mol. Cancer Res., May 1, 2008; 6(5): 770 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. S. Kristensen, T. Mikeska, M. Krypuy, and A. Dobrovic
Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection
Nucleic Acids Res., April 1, 2008; 36(7): e42 - e42.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
A P Moulin, G Clement, F T Bosman, L Zografos, and J Benhattar
Methylation of CpG island promoters in uveal melanoma
Br J Ophthalmol, February 1, 2008; 92(2): 281 - 285.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
N. Kholod, J. Boniver, and P. Delvenne
A New Dimethyl Sulfoxide-Based Method for Gene Promoter Methylation Detection
J. Mol. Diagn., November 1, 2007; 9(5): 574 - 581.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
R. Cortese, F. Eckhardt, M. Volleth, M. Wehnert, U. Koelsch, P. Wieacker, and T. Brune
The retinol acid receptor B gene is hypermethylated in patients with familial partial lipodystrophy
J. Mol. Endocrinol., June 1, 2007; 38(6): 663 - 671.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Esteller
Epigenetic gene silencing in cancer: the DNA hypermethylome
Hum. Mol. Genet., April 15, 2007; 16(R1): R50 - R59.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T. K. Wojdacz and A. Dobrovic
Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation
Nucleic Acids Res., March 19, 2007; 35(6): e41 - e41.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
C. Allegrucci and L.E. Young
Differences between human embryonic stem cell lines
Hum. Reprod. Update, March 1, 2007; 13(2): 103 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
A. Hollestelle, F. Elstrodt, J. H.A. Nagel, W. W. Kallemeijn, and M. Schutte
Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
Mol. Cancer Res., February 1, 2007; 5(2): 195 - 201.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. E. K. Ibrahim, N. P. Thorne, K. Baird, N. L. Barbosa-Morais, S. Tavare, V. P. Collins, A. H. Wyllie, M. J. Arends, and J. D. Brenton
MMASS: an optimized array-based method for assessing CpG island methylation
Nucleic Acids Res., November 6, 2006; 34(20): e136 - e136.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Lopez-Serra, E. Ballestar, M. F. Fraga, M. Alaminos, F. Setien, and M. Esteller
A Profile of Methyl-CpG Binding Domain Protein Occupancy of Hypermethylated Promoter CpG Islands of Tumor Suppressor Genes in Human Cancer.
Cancer Res., September 1, 2006; 66(17): 8342 - 8346.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Cebrian, P. D. Pharoah, S. Ahmed, S. Ropero, M. F. Fraga, P. L. Smith, D. Conroy, R. Luben, B. Perkins, D. F. Easton, et al.
Genetic variants in epigenetic genes and breast cancer risk
Carcinogenesis, August 1, 2006; 27(8): 1661 - 1669.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
B. Khulan, R. F. Thompson, K. Ye, M. J. Fazzari, M. Suzuki, E. Stasiek, M. E. Figueroa, J. L. Glass, Q. Chen, C. Montagna, et al.
Comparative isoschizomer profiling of cytosine methylation: The HELP assay
Genome Res., August 1, 2006; 16(8): 1046 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. Gebhard, L. Schwarzfischer, T. H. Pham, R. Andreesen, A. Mackensen, and M. Rehli
Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR
Nucleic Acids Res., July 5, 2006; 34(11): e82 - e82.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Foltz, G.-Y. Ryu, J.-G. Yoon, T. Nelson, J. Fahey, A. Frakes, H. Lee, L. Field, K. Zander, Z. Sibenaller, et al.
Genome-Wide Analysis of Epigenetic Silencing Identifies BEX1 and BEX2 as Candidate Tumor Suppressor Genes in Malignant Glioma.
Cancer Res., July 1, 2006; 66(13): 6665 - 6674.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Ibanez de Caceres, E. Dulaimi, A. M. Hoffman, T. Al-Saleem, R. G. Uzzo, and P. Cairns
Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
Cancer Res., May 15, 2006; 66(10): 5021 - 5028.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Boix-Chornet, M. F. Fraga, A. Villar-Garea, R. Caballero, J. Espada, A. Nunez, J. Casado, C. Largo, J. I. Casal, J. C. Cigudosa, et al.
Release of Hypoacetylated and Trimethylated Histone H4 Is an Epigenetic Marker of Early Apoptosis
J. Biol. Chem., May 12, 2006; 281(19): 13540 - 13547.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Mulero-Navarro, J.M. Carvajal-Gonzalez, M. Herranz, E. Ballestar, M.F. Fraga, S. Ropero, M. Esteller, and P.M. Fernandez-Salguero
The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding
Carcinogenesis, May 1, 2006; 27(5): 1099 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
M. Bibikova, Z. Lin, L. Zhou, E. Chudin, E. W. Garcia, B. Wu, D. Doucet, N. J. Thomas, Y. Wang, E. Vollmer, et al.
High-throughput DNA methylation profiling using universal bead arrays
Genome Res., March 1, 2006; 16(3): 383 - 393.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Ying, G. Srivastava, W.-S. Hsieh, Z. Gao, P. Murray, S.-K. Liao, R. Ambinder, and Q. Tao
The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors
Clin. Cancer Res., September 15, 2005; 11(18): 6442 - 6449.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Brell, A. Tortosa, E. Verger, J. M. Gil, N. Vinolas, S. Villa, J. J. Acebes, L. Caral, T. Pujol, I. Ferrer, et al.
Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas
Clin. Cancer Res., July 15, 2005; 11(14): 5167 - 5174.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. Agrelo, F. Setien, J. Espada, M. J. Artiga, M. Rodriguez, A. Perez-Rosado, A. Sanchez-Aguilera, M. F. Fraga, M. A. Piris, and M. Esteller
Inactivation of the Lamin A/C Gene by CpG Island Promoter Hypermethylation in Hematologic Malignancies, and Its Association With Poor Survival in Nodal Diffuse Large B-Cell Lymphoma
J. Clin. Oncol., June 10, 2005; 23(17): 3940 - 3947.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. A. Melnikov, R. B. Gartenhaus, A. S. Levenson, N. A. Motchoulskaia, and V. V. Levenson (Chernokhvostov)
MSRE-PCR for analysis of gene-specific DNA methylation
Nucleic Acids Res., June 8, 2005; 33(10): e93 - e93.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
E. Kondo, Z. Gu, A. Horii, and S. Fukushige
The Thymine DNA Glycosylase MBD4 Represses Transcription and Is Associated with Methylated p16INK4a and hMLH1 Genes
Mol. Cell. Biol., June 1, 2005; 25(11): 4388 - 4396.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. C. Brandes, M. van Engeland, K. A.D. Wouters, M. P. Weijenberg, and J. G. Herman
CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype
Carcinogenesis, June 1, 2005; 26(6): 1152 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
U. Lehmann, I. Berg-Ribbe, L. U. Wingen, K. Brakensiek, T. Becker, J. Klempnauer, B. Schlegelberger, H. Kreipe, and P. Flemming
Distinct Methylation Patterns of Benign and Malignant Liver Tumors Revealed by Quantitative Methylation Profiling
Clin. Cancer Res., May 15, 2005; 11(10): 3654 - 3660.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. Mund, V. Beier, P. Bewerunge, M. Dahms, F. Lyko, and J. D. Hoheisel
Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines
Nucleic Acids Res., April 28, 2005; 33(8): e73 - e73.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. L. Gonzalgo, S. Yegnasubramanian, G. Yan, C. G. Rogers, T. L. Nicol, W. G. Nelson, and C. P. Pavlovich
Molecular Profiling and Classification of Sporadic Renal Cell Carcinoma by Quantitative Methylation Analysis
Clin. Cancer Res., November 1, 2004; 10(21): 7276 - 7283.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
A. H. Lund and M. van Lohuizen
Epigenetics and cancer
Genes & Dev., October 1, 2004; 18(19): 2315 - 2335.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
M Lacroix, R-A Toillon, and G Leclercq
Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics
Endocr. Relat. Cancer, September 1, 2004; 11(3): 497 - 522.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. A. Ross and B. A. Spengler
The Conundrum Posed by Cellular Heterogeneity in Analysis of Human Neuroblastoma
J Natl Cancer Inst, August 18, 2004; 96(16): 1192 - 1193.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
M. F. Fraga, M. Herranz, J. Espada, E. Ballestar, M. F. Paz, S. Ropero, E. Erkek, O. Bozdogan, H. Peinado, A. Niveleau, et al.
A Mouse Skin Multistage Carcinogenesis Model Reflects the Aberrant DNA Methylation Patterns of Human Tumors
Cancer Res., August 15, 2004; 64(16): 5527 - 5534.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Sun, D. Deng, W.-C. You, H. Bai, L. Zhang, J. Zhou, L. Shen, J.-L. Ma, Y.-Q. Xie, and J.-Y. Li
Methylation of p16 CpG Islands Associated with Malignant Transformation of Gastric Dysplasia in a Population-Based Study
Clin. Cancer Res., August 1, 2004; 10(15): 5087 - 5093.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Gilbert, S. D. Gore, J. G. Herman, and M. A. Carducci
The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation
Clin. Cancer Res., July 15, 2004; 10(14): 4589 - 4596.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-i. Maruya, J.-P. J. Issa, R. S. Weber, D. I. Rosenthal, J. C. Haviland, R. Lotan, and A. K. El-Naggar
Differential Methylation Status of Tumor-Associated Genes in Head and Neck Squamous Carcinoma: Incidence and Potential Implications
Clin. Cancer Res., June 1, 2004; 10(11): 3825 - 3830.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. G. Herman
Epigenetics in Lung Cancer: Focus on Progression and Early Lesions
Chest, May 1, 2004; 125(5_suppl): 119S - 122S.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Graziano, F. Arduini, A. Ruzzo, I. Bearzi, B. Humar, H. More, R. Silva, P. Muretto, P. Guilford, E. Testa, et al.
Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer
Clin. Cancer Res., April 15, 2004; 10(8): 2784 - 2789.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
F. Graziano, F. Arduini, A. Ruzzo, A. Mandolesi, I. Bearzi, R. Silva, P. Muretto, E. Testa, D. Mari, M. Magnani, et al.
Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs
Ann. Onc., March 1, 2004; 15(3): 489 - 492.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
A. M. Marchevsky, J. A. Tsou, and I. A. Laird-Offringa
Classification of Individual Lung Cancer Cell Lines Based on DNA Methylation Markers: Use of Linear Discriminant Analysis and Artificial Neural Networks
J. Mol. Diagn., February 1, 2004; 6(1): 28 - 36.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. Agathanggelou, I. Bieche, J. Ahmed-Choudhury, B. Nicke, R. Dammann, S. Baksh, B. Gao, J. D. Minna, J. Downward, E. R. Maher, et al.
Identification of Novel Gene Expression Targets for the Ras Association Domain Family 1 (RASSF1A) Tumor Suppressor Gene in Non-Small Cell Lung Cancer and Neuroblastoma
Cancer Res., September 1, 2003; 63(17): 5344 - 5351.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. F. Paz, S. Wei, J. C. Cigudosa, S. Rodriguez-Perales, M. A. Peinado, T. H.-M. Huang, and M. Esteller
Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases
Hum. Mol. Genet., September 1, 2003; 12(17): 2209 - 2219.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Villar-Garea, M. F. Fraga, J. Espada, and M. Esteller
Procaine Is a DNA-demethylating Agent with Growth-inhibitory Effects in Human Cancer Cells
Cancer Res., August 15, 2003; 63(16): 4984 - 4989.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. O. O. Chan, S. K. Lam, B. C.-Y. Wong, Y.-L. Kwong, A. Rashid, and G. Tamura
Gene Methylation in Non-Neoplastic Mucosa of Gastric Cancer: Age or Helicobacter pylori Related?
Am. J. Pathol., July 1, 2003; 163(1): 370 - 373.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.